Releases - RaySearch Laboratories

View:

2007

 

Found press releases

 

COMPASS® receives FDA clearance and is launched

RaySearch Laboratories AB (publ.) and IBA (Ion Beam Applications S.A.: Reuters IBAB.BR and Bloomberg IBAB.BB) announced today that the new dosimetry solution COMPASS® has received 510(k) clearance by the FDA and that it has been launched on the worldwide market through IBA’s business unit IBA Dosimetry.

COMPASS® is a state-of-the-art solution for quality assurance in radiotherapy that has been developed in joint...

RaySearch Laboratories AB (publ) Interim report January 1 – September 30, 2007

JANUARY 1 – SEPTEMBER 30, 2007
• Net sales for the period amounted to SEK 50.2 M (47.8)
• Profit after tax was SEK 16.8 M (16.5)
• Earnings per share after tax amounted to SEK 1.47 (1.44)
• Operating profit amounted to SEK 22.1 M (22.5)
• Cash flow from operating activities amounted to SEK 25.7 M (16.9)
• New collaboration agreement with Varian Medical Systems was signed in May
• New collaboration agreement...

RaySearch Laboratories and TomoTherapy Inc. to show first product concepts at AS...

RaySearch is developing a suite of products under an agreement with TomoTherapy Inc that was announced by RaySearch in August 2007. Three products have now been specified and initial works in progress concepts will be shared at the annual ASTRO meeting in Los Angeles, October 28th – November 1st.

“We are very pleased that the development is progressing at full speed and the fact that we can demonstrate new...

PRESS RELEASE

Stockholm, September 13, 2007

Johan Löf, Erik Hedlund, Anders Brahme, Carl Filip Bergendal, Anders
Liander and Bengt Lind (”the Principal Owners”) divested 561,174 B
shares in RaySearch Laboratories AB (publ) (”RaySearch”). This
corresponds to 1.1 % of the votes and 4.8 % of the capital in RaySearch.
Accordingly, as of September 13, 2007 the Principal Owners hold shares
corresponding to 84.8 % of the votes...

RaySearch Laboratories AB (publ) Interim Report January 1 – June 30, 2007

January 1 – June 30, 2007
• Net sales for the period amounted to SEK 33.5 M (28.6)
• Profit after tax was SEK 10.7 M (8.3)
• Earnings per share after tax amounted to SEK 0.94 (0.72)
• Operating profit amounted to SEK 14.3 M (11.3)
• Cash flow from operating activities amounted to SEK 19,8 M (19.2)
• New collaboration agreement with Varian Medical Systems was signed in May

After the end of the reporting...

Resolutions at Annual General Meeting of RaySearch Laboratories AB (publ)

The Annual General Meeting of RaySearch Laboratories AB (publ), which was held on May 15, 2007, passed the following resolutions, among others.

Johan Löf, Erik Hedlund, Carl Filip Bergendal and Hans Wigzell were re-elected members of the Board, with Erik Hedlund as Chairman of the Board. Thomas Pousette was re-elected deputy member of the Board. It was resolved that the number of Board members shall be four (4)...

Annual Report 2006

.

RaySearch Laboratories AB (publ) Interim Report, January 1–March 31, 2007

• Net sales for the period amounted to SEK 16.1 M (15.5)
• Profit after tax was SEK 5.2 M (5.3)
• Earnings per share after tax amounted to SEK 0.46 (0.47)
• Operating profit amounted to SEK 7.1 M (7.3)
• Cash flow from operating activities was SEK 13.4 M (12.2)

Johan Löf, President and CEO of RaySearch Laboratories AB, comments on the first three months of the year as follows:

“It is highly pleasing...

Varian Medical Systems and RaySearch Laboratories Sign Long-Term Collaboration A...

Varian Medical Systems and RaySearch Laboratories have signed a long-term strategic collaboration agreement in which RaySearch will develop advanced radiation therapy treatment planning software for integration into Varian’s Eclipse™ treatment planning system.
The collaboration involves developing a number of components, including radiobiological optimization software, aimed at improving radiation treatments....

Information published by RaySearch Laboratories AB (publ) from April 1, 2006 th...

In accordance with Finansinspektionen’s (Swedish Financial Supervisory Authority) regulations (FFFS 2007:7) regarding the issuer’s obligation to provide annual information, RaySearch is publishing a compilation of the information that RaySearch has released publicly from April 1, 2006 through April 26, 2007.

Financial reports such as the annual report, year-end report and interim reports, including any comments...

RaySearch Laboratories

RaySearch Laboratories is a medical technology company that develops advanced software solutions for improved radiation therapy of cancer. RaySearch’s products are sold through license agreements with leading partners su...

View more


  CONTACT